- Home
- MCW vs MRUS Comparison
MCW vs MRUS Comparison
Compare MCW & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCW
- MRUS
- Stock Information
- Founded
- MCW 1996
- MRUS 2003
- Country
- MCW United States
- MRUS Netherlands
- Employees
- MCW N/A
- MRUS N/A
- Industry
- MCW
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- MCW
- MRUS Health Care
- Exchange
- MCW Nasdaq
- MRUS Nasdaq
- Market Cap
- MCW 2.4B
- MRUS 2.7B
- IPO Year
- MCW 2021
- MRUS 2016
- Fundamental
- Price
- MCW $7.45
- MRUS $40.90
- Analyst Decision
- MCW Hold
- MRUS Strong Buy
- Analyst Count
- MCW 7
- MRUS 14
- Target Price
- MCW $8.46
- MRUS $87.00
- AVG Volume (30 Days)
- MCW 1.7M
- MRUS 770.0K
- Earning Date
- MCW 04-30-2025
- MRUS 05-07-2025
- Dividend Yield
- MCW N/A
- MRUS N/A
- EPS Growth
- MCW 4.42
- MRUS N/A
- EPS
- MCW 0.24
- MRUS N/A
- Revenue
- MCW $1,017,200,000.00
- MRUS $54,732,000.00
- Revenue This Year
- MCW $7.47
- MRUS $26.81
- Revenue Next Year
- MCW $7.76
- MRUS $23.85
- P/E Ratio
- MCW $31.19
- MRUS N/A
- Revenue Growth
- MCW 8.18
- MRUS 42.77
- 52 Week Low
- MCW $5.84
- MRUS $33.19
- 52 Week High
- MCW $8.60
- MRUS $61.61
- Technical
- Relative Strength Index (RSI)
- MCW 51.62
- MRUS 45.06
- Support Level
- MCW $7.33
- MRUS $37.92
- Resistance Level
- MCW $7.66
- MRUS $46.36
- Average True Range (ATR)
- MCW 0.24
- MRUS 2.58
- MACD
- MCW 0.07
- MRUS -0.27
- Stochastic Oscillator
- MCW 67.73
- MRUS 35.31
About MCW Mister Car Wash Inc.
Mister Car Wash Inc is a car wash brand offering express exterior and interior cleaning services. Express Exterior Locations offers express exterior cleaning services and Interior Cleaning Locations offers both express exterior and interior cleaning services. The company recognizes revenue from activities related to providing car wash services at its car wash locations that are geographically diversified throughout the United States and have similar economic characteristics and nature of services.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.